Top news of the week: 17.08.2022.
Pam Belluck and Stephanie M. Lee share 2022 Victor Cohn Prize
Pam Belluck Pam Belluck began uncovering medical stories as a national bureau chief at the Times, initiating important enterprise stories on Alzheimer’s disease and mental …
High-Fidelity Cas13 Variants Reduce RNA Editing’s Collateral Effects
Efficient on-target RNA degradation, with almost no collateral damage in mammalian cells and animals, has been shown with high fidelity Cas13 variants.
Biopharma stocks climb on upcoming filings, strong data and potential mergers
BioWorld’s Biopharmaceutical Index is at its highest point this year, up 7.85%, showing one of its sharpest rises within the last week. Out of 22 component stocks, 13 are trading above ...
A bioengineered cornea can restore sight to blind people
The implant, made from pig skin protein, could provide visually impaired people with more affordable transplants.
Why is the Quest for Universal Flu and COVID-19 Vaccines Taking so Long?
After more than two decades of attempts to develop a universal influenza vaccine, the global COVID-19 pandemic intensified the need for a broader vaccine for both illnesses.
GEN August 2022: Page 1
Read feature stories, columns, tutorials, and supplements. Discover new products and apps covering genetic engineering & biotechnology news.
Corneal Implants from Pig Skin Restores Sight to Blind in Small Pilot Study
In a small pilot study, the implants were able to restore corneal thickness and curvature to normal levels, and vision outcomes were as good as if human-donated corneas had been used.
Centessa Left with Two Clinical Assets after Second Development Program Halted
Centessa halted ZF874 following the report of an adverse event that involved elevated liver enzymes in a Phase I study. This is the second development program the company has stopped in as ...